Seminars in Nuclear Medicine

Papers
(The median citation count of Seminars in Nuclear Medicine is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Theranostics in Lung Neuroendocrine Tumors111
Letter from the Guest Editors106
Non-FDG hypoxia tracers91
Letter from the Editors61
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques58
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies54
Sentinel Lymph Node Methods in Breast Cancer49
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update47
Imaging of Invasive Fungal Infections- The Role of PET/CT41
FAPI-PET in Cardiovascular Disease40
Molecular Imaging in Inflammatory Bowel Disease38
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer38
Autoimmune Thyroid Diseases38
Artificial Intelligence for Drug Discovery: An Update and Future Prospects37
The Role of Nuclear Medicine in Benign Thyroid Disease36
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy35
Imaging for Radiation Planning in Breast Cancer34
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled33
Prognostic Value of PSMA PET/CT in Prostate Cancer32
Global experience in brain amyloid imaging31
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers31
Total-Body PET/CT: A Role of Artificial Intelligence?30
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects30
The Evolution of Artificial Intelligence in Nuclear Medicine30
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity28
FDG PET/CT for Detection of Infectious Complications Following Solid Organ Transplantation28
Remote Reading and Teaching of Nuclear Medicine in the Era of COVID-1927
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma27
PET/MR Technology: Advancement and Challenges27
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects26
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis25
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I24
Expanding Role for Gallium-68 PET Imaging in Oncology24
New Approaches for Imaging Bacteria23
Standardized PSMA-PET Imaging of Advanced Prostate Cancer23
Use of Radionuclide-Based Imaging Methods in Breast Cancer23
Letter from the Guest Editors22
Total-body PET/CT – First Clinical Experiences and Future Perspectives21
Letter From the Editors21
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices21
18F-Fluoride PET/CT—Updates20
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology20
Impact of COVID-19 on Nuclear Medicine in Asia19
Update on Pediatric Nuclear Medicine in Acute Care19
FDG PET/CT for Staging Lung Carcinoma: An Update19
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine19
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review18
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?18
Letter from the Editors18
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases18
Nuclear Medicine Preclinical Research: The Role of Cell Cultures17
The Impact of PSMA PET/CT Imaging in Prostate Cancer Radiation Treatment16
The Clinical Utility of Molecular Imaging in COVID-19: An Update16
Targeted Radiopharmaceutical Therapy for Bone Metastases16
Diagnosis and Image-guided Therapy of Cardiac Left Ventricular Assist Device Infections16
Safe Pulmonary Scintigraphy in the Era of COVID-1916
Functional Imaging of Testicular Torsion16
Radiolabeled Somatostatin Analogs for Cancer Imaging16
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine15
The Impact of COVID-19 on Nuclear Medicine in Europe15
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends15
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma15
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?15
Letter from the Editors14
FDG-PET/CT Variants and Pitfalls in Haematological Malignancies14
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET14
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace14
Artificial Intelligence and Workforce Diversity in Nuclear Medicine14
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget14
A Role of Non-FDG Tracers in Lung Cancer?13
Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy13
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers13
PET/CT Variants and Pitfalls in Gynecological Cancers13
Prostate Cancer Theranostics With 177Lu-PSMA13
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma13
Telehealth in Multidisciplinary Target Delineation for Radiotherapy During the COVID-19 Pandemic. A Review and a Case13
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides13
FDG-PET/CT of COVID-19 and Other Lung Infections13
Imaging in Renal Transplants: An Update12
Letter From the Editors12
Radiation Dose to Pediatric Patients From Radiopharmaceuticals12
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging12
PET Assessment of Cardiac Allograft Vasculopathy12
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging12
Letter From the Guest Editors12
COVID-19 Pandemic: What Have We Learned and What to Expect in the Future?12
Advances in PET/CT Technology: An Update11
Letter from the Editors11
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence11
Total Body PET/CT: A Role in Musculoskeletal Diseases11
Pitfalls on PET/MRI11
Cardiac PET/MRI: Recent Developments and Future Aspects11
Cardiovascular Imaging in Women11
Preclinical Evaluation of Novel PET Probes for Dementia10
Letter From the Editors10
Parathyroid Imaging10
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational10
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy10
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis10
Letter from the Editors10
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce9
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases9
PET Agents in Dementia: An Overview9
Letter from the Editors9
Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting9
Advances in Brain Amyloid Imaging9
FDG PET/CT for Staging and Restaging Malignant Mesothelioma9
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone8
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer8
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies8
Clinical Management of COVID-19 Patients – An Update8
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review8
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging8
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update8
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update8
Molecular imaging Theranostics of Neuroendocrine Tumors8
PET/CT Variants and Pitfalls in Breast Cancers8
Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies8
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma8
Imaging of Bone Metastases in Breast Cancer8
Pitfalls of Radionuclide Renal Imaging in Pediatrics8
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?8
AI in SPECT Imaging: Opportunities and Challenges7
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?7
Imaging Approach to Disease of the Pleura7
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma7
Application of Deep Learning in Breast Cancer Imaging7
FDG PET/CT Imaging of Sarcoidosis7
Letter from the Editors7
Advances in PSMA Alpha Theragnostics7
Advancement in Production of Radiotracers7
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer7
Letter From the Editors7
Current and Future Perspectives of PDL1 PET and SPECT Imaging7
Letter from the Editors7
Combination Strategies and Targeted Radionuclide Therapies7
Imaging of Cardiac Transplantation: An Overview7
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers7
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain7
FDG PET for Assessment of Autologous Stem Cell Transplantation6
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends6
PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas6
FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer6
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review6
Letter from the Editors6
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer6
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging6
Letter From the Editors6
Practical Considerations When Interpreting FDG PET/CT Imaging for Staging and Treatment Response Assessment in Melanoma Patients6
The Current Role of Tau PET Imaging in Neurodegeneration6
Clinical Use of PET/MR in Oncology: An Update6
How to Report PSMA PET5
PET/CT in Bladder Cancer: An Update5
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma5
18F-FDG PET/CT for Response Assessment in Lung Cancer5
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update5
The Impact of Radiopharmaceutical Therapy on Renal Function5
Molecular and Anatomical Imaging of Dementia With Lewy Bodies and Frontotemporal Lobar Degeneration5
Total Body PET-CT Protocols in Oncology5
Molecular Imaging of Tuberculosis5
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer5
Molecular Imaging of Fever of Unknown Origin: An Update5
PET Imaging in Neurodegeneration and Neuro-oncology: Variants and Pitfalls5
Potential of Technetium and Rhenium Theranostics5
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting5
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care5
18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD)5
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma5
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art5
0.30969595909119